By Frank Prenesti
Date: Thursday 23 Feb 2023
(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.
| Currency | US Dollars |
| Share Price | $ 135.93 |
| Change Today | $ 4.79 |
| % Change | 3.65 % |
| 52 Week High | $136.30 |
| 52 Week Low | $92.92 |
| Volume | 13,180,915 |
| Shares Issued | 1,246.00m |
| Market Cap | $169,369m |
| RiskGrade | 120 |
| Strong Buy | 10 |
| Buy | 13 |
| Neutral | 5 |
| Sell | 1 |
| Strong Sell | 0 |
| Total | 29 |

| Time | Volume / Share Price |
| 16:00 | 1,575,008 @ $135.93 |
| 15:59 | 100 @ $135.96 |
| 15:59 | 448 @ $135.94 |
| 15:59 | 4,101 @ $135.94 |
| 15:59 | 216 @ $135.94 |
You are here: research